These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094 [TBL] [Abstract][Full Text] [Related]
5. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373 [TBL] [Abstract][Full Text] [Related]
6. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [TBL] [Abstract][Full Text] [Related]
7. Is it possible to predict para-aortic lymph node metastasis in endometrial cancer? Turan T; Hizli D; Sarici S; Boran N; Gundogdu B; Karadag B; Tulunay G; Kose MF Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):274-9. PubMed ID: 21664758 [TBL] [Abstract][Full Text] [Related]
8. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063 [TBL] [Abstract][Full Text] [Related]
9. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary. Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer. Garg G; Morris RT; Solomon L; Toy EP; Kruger M; Clary K; Munkarah A; Wright JD Gynecol Oncol; 2011 Nov; 123(2):208-13. PubMed ID: 21821278 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer. Polterauer S; Khalil S; Zivanovic O; Abu-Rustum NR; Hofstetter G; Concin N; Grimm C; Reinthaller A; Barakat RR; Leitao MM Obstet Gynecol; 2012 Jun; 119(6):1210-8. PubMed ID: 22617586 [TBL] [Abstract][Full Text] [Related]
13. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Kanazawa K; Suzuki T; Tokashiki M Gynecol Oncol; 1999 May; 73(2):237-41. PubMed ID: 10329040 [TBL] [Abstract][Full Text] [Related]
14. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. Steven K; Poulsen AL J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113 [TBL] [Abstract][Full Text] [Related]